Tempo Scan Pacific Tbk PT
IDX:TSPC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 750
2 840
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tempo Scan Pacific Tbk PT
Other Receivables
Tempo Scan Pacific Tbk PT
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Receivables
Rp165.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Receivables
Rp291B
|
CAGR 3-Years
37%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Receivables
Rp45.6B
|
CAGR 3-Years
41%
|
CAGR 5-Years
40%
|
CAGR 10-Years
13%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Receivables
Rp237.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Receivables
Rp2.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Receivables
Rp342.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
50%
|
|
Tempo Scan Pacific Tbk PT
Glance View
PT Tempo Scan Pacific Tbk engages in the pharmaceutical business. The company is headquartered in Jakarta, Dki Jakarta and currently employs 4,725 full-time employees. The firm has three core business divisions: pharmaceutical division, consumer products and cosmetics division and distribution division. Its pharmaceutical division manufactures and markets various over-the-counter (OTC) and ethical drugs as well as supplements. Its manufacturing plants are located in Bekasi, Indonesia. Its consumer products and cosmetics division manufactures and markets various consumer products, such as soap, household products and cosmetics. Its manufacturing plants are located in Pulogadung, Bekasi and Surabaya, Indonesia. Its distribution division distributes its products and third-party products. Its subsidiaries include PT Supra Ferbindo, PT Tempo Rx Farma, PT Tempo Nagadi, PT Rudy Soetadi, PT Perusahaan Dagang Tempo and PT Supra Usadhatama.
See Also
What is Tempo Scan Pacific Tbk PT's Other Receivables?
Other Receivables
165.3B
IDR
Based on the financial report for Sep 30, 2024, Tempo Scan Pacific Tbk PT's Other Receivables amounts to 165.3B IDR.
What is Tempo Scan Pacific Tbk PT's Other Receivables growth rate?
Other Receivables CAGR 3Y
28%
Over the last year, the Other Receivables growth was 19%. The average annual Other Receivables growth rates for Tempo Scan Pacific Tbk PT have been 28% over the past three years .
You don't have any saved screeners yet
